XOMA Corporation EV - Enterprise Value 2011-2026 | XOMA

Annual EV - Enterprise Value XOMA Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
416 M	358 M	-7.43 M	-41.2 M	179 M	341 M	199 M	101 M	250 M	75.5 M	130 M	391 M	730 M	206 M	58.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
730 M	-41.2 M	226 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Compugen Ltd. CGEN	291 M	$ 2.86	3.62 %	$ 267 M	Israel
FSD Pharma HUGE	4.15 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Enlivex Therapeutics Ltd. ENLV	122 M	$ 0.8	-3.59 %	$ 36.6 M	Israel
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-4.92 M	-	-	$ 269 M	USA
Exelixis EXEL	11.9 B	$ 46.21	-5.11 %	$ 12.5 B	USA
Fortress Biotech FBIO	122 M	$ 2.4	-5.88 %	$ 67 M	USA
BioNTech SE BNTX	-4.91 B	$ 93.02	-2.35 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Forte Biosciences FBRX	280 M	$ 26.17	-1.32 %	$ 339 M	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.56	5.03 %	$ 3.74 B	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	1.16 B	$ 3.14	-0.32 %	$ 653 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.54	3.51 %	$ 5.83 M	Israel
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Genprex GNPX	-3.98 M	$ 0.87	-2.84 %	$ 811 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 20.66	-14.52 %	$ 2.63 B	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Genmab A/S GMAB	27 B	$ 27.06	-2.98 %	$ 16.7 B	Danmark
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	4.38 B	$ 52.42	-4.83 %	$ 4.71 B	Schweiz
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.61	-5.29 %	$ 428 M	Britain
Heron Therapeutics HRTX	411 M	$ 1.24	-5.34 %	$ 207 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA